For this reason, the effects of CgA on neuroendocrine tumors could be different from those observed in murine models of nonneuroendocrine tumors (and difficult to predict), considering the high concentration that CgA can reach in the tumor microenvironment because of the secretory activity of neuroendocrine cancer cells. This evidence concerns the gene CGA and neoplasm.